Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2012

Fore Pharma, October 2012, Pages: 24

Fore Pharma announced the results of its Acute Coronary Syndrome patient population study in a new report ‘Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2012’. The report provides insights into Acute Coronary Syndrome epidemiology, Acute Coronary Syndrome diagnosed patients, and Acute Coronary Syndrome treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Acute Coronary Syndrome derived from epidemiological analysis, percentage of patients diagnosed with Acute Coronary Syndrome, and percentage of patients treated with Acute Coronary Syndrome therapy.

The study helps executives estimate Acute Coronary Syndrome market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Acute Coronary Syndrome prevalence, Acute Coronary Syndrome diagnosis rate, and Acute Coronary Syndrome treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Acute Coronary Syndrome: Disease Definition
- Acute Coronary Syndrome Patient Flow
- Acute Coronary Syndrome Prevalence
- Acute Coronary Syndrome Diagnosed Patients
- Acute Coronary Syndrome Treated Patients

1. Acute Coronary Syndrome: Disease Definition
2. Global Acute Coronary Syndrome Patient Flow
2A. Global Acute Coronary Syndrome Prevalence
2B. Global Acute Coronary Syndrome Diagnosed Patients
2C. Global Acute Coronary Syndrome Treated Patients
3. Acute Coronary Syndrome Patient Flow in the US
3A. Acute Coronary Syndrome Prevalence in the US
3B. Acute Coronary Syndrome Diagnosed Patients in the US
3C. Acute Coronary Syndrome Treated Patients in the US
4. Acute Coronary Syndrome Patient Flow in Europe
4A. Acute Coronary Syndrome Prevalence in Europe
4B. Acute Coronary Syndrome Diagnosed Patients in Europe
4C. Acute Coronary Syndrome Treated Patients in Europe
5. Acute Coronary Syndrome Patient Flow in Germany
5A. Acute Coronary Syndrome Prevalence in Germany
5B. Acute Coronary Syndrome Diagnosed Patients in Germany
5C. Acute Coronary Syndrome Treated Patients in Germany
6. Acute Coronary Syndrome Patient Flow in France
6A. Acute Coronary Syndrome Prevalence in France
6B. Acute Coronary Syndrome Diagnosed Patients in France
6C. Acute Coronary Syndrome Treated Patients in France
7. Acute Coronary Syndrome Patient Flow in Spain
7A. Acute Coronary Syndrome Prevalence in Spain
7B. Acute Coronary Syndrome Diagnosed Patients in Spain
7C. Acute Coronary Syndrome Treated Patients in Spain
8. Acute Coronary Syndrome Patient Flow in Italy
8A. Acute Coronary Syndrome Prevalence in Italy
8B. Acute Coronary Syndrome Diagnosed Patients in Italy
8C. Acute Coronary Syndrome Treated Patients in Italy
9. Acute Coronary Syndrome Patient Flow in UK
9A. Acute Coronary Syndrome Prevalence in UK
9B. Acute Coronary Syndrome Diagnosed Patients in UK
9C. Acute Coronary Syndrome Treated Patients in UK
10. Acute Coronary Syndrome Patient Flow in Japan
10A. Acute Coronary Syndrome Prevalence in Japan
10B. Acute Coronary Syndrome Diagnosed Patients in Japan
10C. Acute Coronary Syndrome Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources

Table 1: Global Acute Coronary Syndrome Patient Flow (2012)
Table 2: Global Acute Coronary Syndrome Patient Flow Forecast (2012-2019)
Table 3: Acute Coronary Syndrome Patient Flow in the US (2012)
Table 4: Acute Coronary Syndrome Patient Flow Forecast in the US (2012-2019)
Table 5: Acute Coronary Syndrome Patient Flow in Europe (2012)
Table 6: Acute Coronary Syndrome Patient Flow Forecast in Europe (2012-2019)
Table 7: Acute Coronary Syndrome Patient Flow in Germany (2012)
Table 8: Acute Coronary Syndrome Patient Flow Forecast in Germany (2012-2019)
Table 9: Acute Coronary Syndrome Patient Flow in France (2012)
Table 10: Acute Coronary Syndrome Patient Flow Forecast in France (2012-2019)
Table 11: Acute Coronary Syndrome Patient Flow in Spain (2012)
Table 12: Acute Coronary Syndrome Patient Flow Forecast in Spain (2012-2019)
Table 13: Acute Coronary Syndrome Patient Flow in Italy (2012)
Table 14: Acute Coronary Syndrome Patient Flow Forecast in Italy (2012-2019)
Table 15: Acute Coronary Syndrome Patient Flow in UK (2012)
Table 16: Acute Coronary Syndrome Patient Flow Forecast in UK (2012-2019)
Table 17: Acute Coronary Syndrome Patient Flow in Japan (2012)
Table 18: Acute Coronary Syndrome Patient Flow Forecast in Japan (2012-2019)

Figure 1: Global Acute Coronary Syndrome Patient Flow (2012)
Figure 2: Global Acute Coronary Syndrome Patient Flow Forecast (2012-2019)
Figure 3: Acute Coronary Syndrome Patient Flow in the US (2012)
Figure 4: Acute Coronary Syndrome Patient Flow Forecast in the US (2012-2019)
Figure 5: Acute Coronary Syndrome Patient Flow in Europe (2012)
Figure 6: Acute Coronary Syndrome Patient Flow Forecast in Europe (2012-2019)
Figure 7: Acute Coronary Syndrome Patient Flow in Germany (2012)
Figure 8: Acute Coronary Syndrome Patient Flow Forecast in Germany (2012-2019)
Figure 9: Acute Coronary Syndrome Patient Flow in France (2012)
Figure 10: Acute Coronary Syndrome Patient Flow Forecast in France (2012-2019)
Figure 11: Acute Coronary Syndrome Patient Flow in Spain (2012)
Figure 12: Acute Coronary Syndrome Patient Flow Forecast in Spain (2012-2019)
Figure 13: Acute Coronary Syndrome Patient Flow in Italy (2012)
Figure 14: Acute Coronary Syndrome Patient Flow Forecast in Italy (2012-2019)
Figure 15: Acute Coronary Syndrome Patient Flow in UK (2012)
Figure 16: Acute Coronary Syndrome Patient Flow Forecast in UK (2012-2019)
Figure 17: Acute Coronary Syndrome Patient Flow in Japan (2012)
Figure 18: Acute Coronary Syndrome Patient Flow Forecast in Japan (2012-2019)

Customers who bought this item also bought

• Global Acute Coronary Syndrome Drug Pipeline Capsule - 2012
• Medical Nutrition - A Global Market Overview
• Coronary Stents - Global Strategic Business Report
• Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report
• Disinfectants - Global Strategic Business Report
• Cardiac Biomarkers - Global Strategic Business Report
• Bariatric (Obesity) Surgical Devices - Global Strategic Business Report
• Acute Ischemic Stroke (Event Driven)
• Patient Monitors: Equipment & Accessories – A Global Market Overview
• European Markets for Interventional Cardiology Devices 2011 (15 Countries)